Provided by Tiger Fintech (Singapore) Pte. Ltd.

Conmed

44.53
+1.132.60%
Volume:239.26K
Turnover:10.62M
Market Cap:1.38B
PE:12.58
High:44.84
Open:42.90
Low:42.77
Close:43.40
52wk High:78.00
52wk Low:42.50
Shares:30.95M
Float Shares:30.68M
Volume Ratio:0.80
T/O Rate:0.78%
Dividend:0.80
Dividend Rate:1.80%
EPS(TTM):3.54
EPS(LYR):4.29
ROE:11.69%
ROA:4.03%
PB:1.37
PE(LYR):10.37

Loading ...

Conmed Cut to Hold From Buy by Needham

Dow Jones
·
Jun 12

BUZZ-Conmed slips after Needham downgrade

Reuters
·
Jun 12

Needham Downgrades CONMED to Hold From Buy, Removes $61 Price Target

MT Newswires Live
·
Jun 12

CONMED Corporation Concluded Annual Stockholder Meeting

Reuters
·
May 22

Conmed Keeps Quarterly Dividend at $0.20 per Share, Payable July 3 to Holders of Record as of June 13

MT Newswires Live
·
May 21

CONMED Names LaVerne Council as Board Chair

MT Newswires Live
·
May 21

BRIEF-Conmed Corporation Appoints Laverne Council As Chair Of The Board Of Directors

Reuters
·
May 21

CONMED Corporation Appoints LaVerne Council as New Chair of the Board, Succeeding Martha Goldberg Aronson

Reuters
·
May 21

CONMED Corporation Announces Quarterly Cash Dividend of $0.20 Per Share

Reuters
·
May 21

Press Release: CONMED Corporation Announces Quarterly Cash Dividend

Dow Jones
·
May 21

CONMED Corporation Files Initial Beneficial Ownership Statement for VP GM International Stephan Epinette

Reuters
·
May 15

Conmed Is Maintained at Equal-Weight by Wells Fargo

Dow Jones
·
May 01

CVS Health Posts Better-Than-Expected Earnings, Joins CommScope, Microsoft, Meta, Chart Industries, And Other Big Stocks Moving Higher On Thursday

Benzinga
·
May 01

Stock Track | Conmed Soars 11.99% on Strong Q1 Earnings, BioBrace Success, Despite Analyst Downgrades

Stock Track
·
May 01

Stock Track | Conmed Surges 6.90% Pre-Market on Strong Q1 Earnings, Despite Analyst Price Target Cuts

Stock Track
·
May 01

Conmed Is Maintained at Buy by Needham

Dow Jones
·
May 01

U.S. RESEARCH ROUNDUP-Avepoint, Meta, United Therapeutics

Reuters
·
May 01

Conmed Corp reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
May 01

Conmed Q1 Adj. EPS $0.85 Beats $0.81 Estimate, Sales $321.30M Beat $313.37M Estimate

Benzinga
·
May 01

BRIEF-Conmed Q1 Adjusted EPS USD 0.95 Vs. IBES Estimate USD 0.81

Reuters
·
May 01